Table of Content



Chapter 1 Research Objective
1.1 Objective - 1:
1.2 Objective - 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Component
2.2.2 Facility Type
2.3 Competitive Insights
2.4 U.S. Cath Labs Market Snapshot
Chapter 3 U.S. Cath Labs Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.3 Penetration and Growth Prospect Mapping
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising incidence of cardiovascular diseases
3.4.1.2 Low operational cost
3.4.1.3 Technological advancement
3.4.2 Market Restraint Analysis
3.4.2.1 Lack of reimbursement for independent labs
3.4.2.2 High maintenance cost for multispecialty labs
3.5 Business Environment Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.1.1 Competitive rivalry
3.5.1.2 Threat of new entrants
3.5.1.3 Bargaining power of buyers
3.5.1.4 Bargaining power of suppliers
3.5.1.5 Threat of substitutes
3.5.2 PEST Analysis
3.5.2.1 Political Landscape
3.5.2.2 Economic and Social Landscape
3.5.2.3 Technology Landscape
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 LICENSING & PARTNERSHIP
3.6.2 Mergers & Acquisitions
Chapter 4 U.S. Cath Labs Market: Component Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 U.S. Cath Labs Market: Component Movement Analysis, USD Million, 2019 & 2027
4.2.1 Services
4.2.1.1 Services market, 2016 - 2027 (USD Million)
4.2.1.2 Therapeutic services
4.2.1.2.1 Therapeutic services market, 2016 - 2027 (USD Million)
4.2.1.2.2 Angioplasty
4.2.1.2.2.1 Angioplasty market, 2016 - 2027 (USD Million)
4.2.1.2.3 Stent Placement
4.2.1.2.3.1 Stent Placement market, 2016 - 2027 (USD Million)
4.2.1.2.4 Rotational atherectomy
4.2.1.2.4.1 Rotational atherectomy market, 2016 - 2027 (USD Million)
4.2.1.2.5 Thrombectomy
4.2.1.2.5.1 Thrombectomy market, 2016 - 2027 (USD Million)
4.2.1.2.6 Cardioversion
4.2.1.2.6.1 Cardioversion market, 2016 - 2027 (USD Million)
4.2.1.2.7 Transcatheter Aortic Valve Replacement (TAVR)
4.2.1.2.7.1 Transcatheter Aortic Valve Replacement (TAVR) market, 2016 - 2027 (USD Million)
4.2.1.2.8 Others
4.2.1.2.8.1 Others market, 2016 - 2027 (USD Million)
4.2.1.3 Diagnostic services
4.2.1.3.1 Diagnostic services market, 2016 - 2027 (USD Million)
4.2.1.3.2 Angiography
4.2.1.3.2.1 Angiography market, 2016 - 2027 (USD Million)
4.2.1.3.3 Coronary intravascular ultrasound
4.2.1.3.3.1 Coronary intravascular ultrasound market, 2016 - 2027 (USD Million)
4.2.1.3.4 Cardiac catheterization
4.2.1.3.4.1 Cardiac catheterization market, 2016 - 2027 (USD Million)
4.2.1.3.5 ECG/EKG
4.2.1.3.5.1 ECG/EKG market, 2016 - 2027 (USD Million)
4.2.1.3.6 Fractional Flow Reserve (FFR)
4.2.1.3.6.1 Fractional Flow Reserve (FFR) market, 2016 - 2027 (USD Million)
4.2.1.3.7 Others
4.2.1.3.7.1 Others market, 2016 - 2027 (USD Million)
4.2.2 Equipment
4.2.2.1 Equipment market, 2016 - 2027 (USD Million)
Chapter 5 U.S. Cath Labs Market: Facility Type Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 U.S. Cath Labs Market: Facility Type Movement Analysis, USD Million, 2019 & 2027
5.2.1 Independent Labs
5.2.1.1 Independent Labs market, 2016 - 2027 (USD Million)
5.2.2 Hospital based labs
5.2.2.1 Hospital based labs market, 2016 - 2027 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players)
6.2 Recent Developments & Impact Analysis, by Key Market Participants
6.2.1 Company market position analysis (Overall revenue, market presence, product portfolio, geographic presence, strategic initiatives)
6.3 Company Profiles
6.3.1 GE Healthcare
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.1.5 SWOT analysis
6.3.2 Siemens Healthineers
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.2.5 SWOT analysis
6.3.3 Koninklijke Philips N.V
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.3.5 SWOT analysis
6.3.4 Shimadzu Corporation
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.4.5 SWOT analysis
6.3.5 Johnson & Johnson
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.5.5 SWOT analysis
6.3.6 Medtronic PLC
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.6.5 SWOT analysis
6.3.7 B. Braun Melsungen AG
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.7.5 SWOT analysis
Chapter 7 Recommendations
Chapter 8 Research Methodology & Scope
8.1 Research Methodology
8.1.1 Information Procurement
8.1.1.1 Purchased database:
8.1.1.2 GVR’s internal database
8.1.2 Primary Research
8.2 Research Scope and Assumptions
8.3 List to Data Sources



List of Tables



TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation